John Majercak

John Majercak has a diverse background in the field of biology and has held various leadership positions in major pharmaceutical and biotechnology companies. John currently serves as the Head of Antibody Discovery at LAMPIRE BIOLOGICAL LABORATORIES. Prior to this, they were the Vice President and Head of Antibody Discovery at Molecular Templates, where they specialized in antibody discovery using custom Bcell and Phage platforms. John also worked as an Associate Director at Bristol Myers Squibb, leading the "Molecular Rescue" Team and applying Next Generation Sequencing technologies to explore therapeutic antibody development. Before that, they were a Principal Scientist at Johnson & Johnson, focusing on therapeutic antibody discovery and immune response modulation. John also worked as a Principal Scientist at Boehringer Ingelheim, managing teams focused on therapeutic antibody development for cancer. Earlier in their career, they held positions at Merck and Novartis, specializing in target identification and lead optimization for neuroscience and functional genomics.

John Majercak earned a PhD degree in Biochemistry from Rutgers University. The duration of their studies and the precise year of completion, however, are unavailable.